What does Ironsail Pharma pricing mean for a clinic P&L?

You can plan the structure: which SKUs drive volume, expected refill cadence, and the patient price points your market supports. What you cannot plan up front with Ironsail Pharma is the COGS number itself, because per-vial rates appear only inside ImpetusRX after provider signup. That gap matters most for high-volume GLP-1 programs, where a small per-vial difference multiplied across hundreds of monthly refills swings the bottom line. After onboarding, pull written per-vial cost on your top three SKUs across at least two pharmacy options and confirm whether shipping is in the tile.

Also clarify how ancillary costs hit the P&L. Marketplace comparison may show a drug rate without cold-chain shipping on GLP-1s, or without any ImpetusRX fee layer. Build your margin model on the all-in number per vial delivered, not the lowest comparison tile alone, so your patient pricing protects the spread you actually need.

Fizy Health inverts the planning problem for clinics that keep their existing EMR. It shows resolved per-vial 503A cost on each catalog and cart line before checkout, with a separately disclosed facilitation fee at payment. For a P&L, that means COGS is a number you can read before you commit, so you can set patient pricing and project gross margin from day one instead of after ImpetusRX onboarding.

Building the whole refill day in one cart reinforces the model: each line shows its cost, so you can see total COGS for a batch and the margin it implies before you submit a single payment. Owners who manage to a target gross margin get a faster loop — see cost, set price, confirm spread — without browsing pharmacy tiles inside a new EMR first.